Lymphoma: all 5,624 studies
Page 48 of 57. Open to participants first (824), then studies with results posted, then the rest; newest registration first within each.
- Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular LymphomaStatus unknownNCT00435955Phase 3
- Study of SGN-40 in Patients With Relapsed Diffuse Large B-Cell LymphomaCompletedNCT00435916Phase 2
- Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous TransplantCompletedNCT00434629Phase 1
- Combination Chemotherapy in Treating Young Patients With Hodgkin's LymphomaCompletedNCT00433459Phase 3
- Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's LymphomaStatus unknownNCT00433433Phase 3
- Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.TerminatedNCT00432419Phase 1/2
- A Study of APO866 for the Treatment of Cutaneous T-cell LymphomaCompletedNCT00431912Phase 2
- Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic MalignanciesCompletedNCT00430846Phase 1
- Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell LymphomaCompletedNCT00430053
- Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.Status unknownNCT00429065
- Endothelial Function and IMT in Survivors of Hodgkin's LymphomaCompletedNCT00428688
- Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's LymphomaCompletedNCT00428142Phase 2
- Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-untreated Follicular Lymphoma (FL)CompletedNCT00427856Phase 2
- Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal MetastasesCompletedNCT00424242Early Phase 1
- Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseNo longer availableNCT00423826
- Safety Study of NHL With 90Y-hLL2 IgGCompletedNCT00421395Phase 1/2
- Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow CancersTerminatedNCT00421213Phase 2
- Compassionate Use of Vorinostat for the Treatment of Patients With Advanced Cutaneous T-Cell Lymphoma (0683-042)No longer availableNCT00419367
- Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment RegimensTerminatedNCT00419081Phase 2
- Clinical Study of Chemoradiation Followed by VIPD in Nasal Natural Killer (NK)/T-cell LymphomaCompletedNCT00418535Phase 2
- Combination Chemotherapy and/or Radiation Therapy in Treating Young Patients With Hodgkin's LymphomaStatus unknownNCT00417014Not applicable
- Intrathecal Rituximab in Treating Patients With Recurrent CNS LymphomaCompletedNCT00416923Phase 1
- Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's LymphomaCompletedNCT00416832Phase 2
- Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS LymphomaCompletedNCT00416819Not applicable
- Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's LymphomaStatus unknownNCT00416377Not applicable
- Efficacy and Safety of Treatment With a Single Dose of 90Y-ibritumomab Tiuxetan in Patients With Low Tumor Burden Untreated or Indolent NHLWithdrawnNCT00414089Phase 2
- Study of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaCompletedNCT00413075Phase 1
- LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell LymphomaCompletedNCT00412997Phase 1
- A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's DiseaseCompletedNCT00412321Phase 1
- Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid MalignanciesCompletedNCT00410982Phase 1
- Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantCompletedNCT00410657Phase 2
- Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)CompletedNCT00407303Phase 1/2
- A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid MalignanciesCompletedNCT00406809Phase 1/2
- Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or LymphomaCompletedNCT00406757Phase 1
- Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for CancerWithdrawnNCT00402935
- Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9Status unknownNCT00400907
- ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor CellsCompletedNCT00400556Phase 1
- A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-cell Lymphoma: NHL-13CompletedNCT00400478Phase 3
- Combination Chemotherapy in Treating Young Male Patients With Hodgkin's LymphomaCompletedNCT00398554Phase 2
- Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody TreatmentCompletedNCT00398372Not applicable
- Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's LymphomaStatus unknownNCT00397800Phase 1/2
- Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory LymphomaCompletedNCT00396864Phase 1
- Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell LymphomaCompletedNCT00394693Phase 2
- Safety and Efficacy of Fludarabine and Cyclophosphamide + RituximabCompletedNCT00393107Phase 2
- Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous TreatmentCompletedNCT00392691Phase 1
- Tailored Therapy for Hodgkin Lymphoma Using Early Interim Therapy PET for Therapy Decision.CompletedNCT00392314Phase 2
- AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's LymphomaCompletedNCT00390117Phase 1
- Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's LymphomaWithdrawnNCT00389506Not applicable
- Trial of Two Schedules of Perifosine for Patients With Solid Tumors or LymphomasCompletedNCT00389077Phase 2
- A Phase I Study of Bendamustine Hydrochloride in Patients With Indolent B-cell Non-Hodgkin's LymphomaCompletedNCT00389051Phase 1
- Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive LymphomaCompletedNCT00388531Phase 2
- Rituximab Combined With Chemotherapy in Burkitt's LymphomaCompletedNCT00388193Phase 2
- ABT-888 in Patients With Refractory Solid Tumors or Hematologic CancerCompletedNCT00387608Phase 1
- Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive CancerWithdrawnNCT00387530Phase 2
- Yt90 Zevalin and Combination Chemotherapy (Z-CHOP)in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-cell LymphomaTerminatedNCT00386321Phase 2
- Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-LymphomaStatus unknownNCT00384553Phase 1/2
- Retreatment Study of Galiximab + Rituximab in Follicular Non-Hodgkin's Lymphoma (NHL)TerminatedNCT00384150Phase 3
- Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell TransplantationCompletedNCT00383994Phase 1
- Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's LymphomaActive, not recruitingNCT00379041Phase 3
- Involved Field Radiotherapy for Non-gastric Marginal Zone LymphomaStatus unknownNCT00377195Phase 2
- Alvocidib in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaTerminatedNCT00377104Phase 1
- Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell LymphomaCompletedNCT00377052Phase 2
- Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other DiseasesCompletedNCT00376922Not applicable
- Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic DiseasesTerminatedNCT00376519Phase 1
- Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell LymphomasCompletedNCT00374699Phase 1/2
- Velcade in MALT Lymphoma PatientsCompletedNCT00373906Phase 2
- Thalidomide in Mucosa Associated Lymphoid Tissue (MALT) Lymphoma PatientsCompletedNCT00373646Phase 2
- Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)Active, not recruitingNCT00368082Phase 1
- Safety and Efficacy Study of Salvage Chemotherapy (R-ESHAP) to Treat Relapsed and Refractory Aggressive Non-Hodgkin's LymphomaTerminatedNCT00367497Phase 2
- Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney CancerCompletedNCT00365287Phase 1/2
- Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's DiseaseCompletedNCT00364676Phase 1
- A Study of Galiximab + Rituximab Versus Rituximab + Placebo in Follicular Non-Hodgkin's Lymphoma (NHL)TerminatedNCT00363636Phase 3
- A Study Evaluating IV Oncaspar® and IV Gemzar® in the Treatment of Solid Tumors and LymphomaTerminatedNCT00363610Phase 1
- Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LymphomaCompletedNCT00363272Phase 1
- Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's LymphomaStatus unknownNCT00363090Phase 1/2
- Ph II CHOP+Velcade in Mediastinal LBCLTerminatedNCT00361621Phase 2
- Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLSCompletedNCT00360438Phase 1/2
- Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Hodgkin's LymphomaCompletedNCT00359892Phase 2
- Study of MGCD0103 Given Three Times Weekly in Patients With Relapsed and Refractory LymphomaCompletedNCT00359086Phase 2
- Study of MGCD0103 (MG-0103) in Patients With Relapsed or Refractory Hodgkin's LymphomaTerminatedNCT00358982Phase 2
- Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's LymphomaCompletedNCT00354926Phase 1
- Fludarabine,Cyclophosphamide and Rituximab Followed by Zevalin for Non-Follicular Indolent Lymphomas.TerminatedNCT00354822Phase 2
- PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or LymphomaTerminatedNCT00354185Phase 1
- Agriculture Health StudyActive, not recruitingNCT00352924
- S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaCompletedNCT00352443Phase 1
- Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With CancerStatus unknownNCT00349024Not applicable
- PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or LymphomasCompletedNCT00348985Phase 1
- Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's LymphomaCompletedNCT00347971Phase 1
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic MalignanciesCompletedNCT00343798Phase 1
- Interdisciplinary Case-Control Study of Non-Hodgkin's LymphomaCompletedNCT00341952
- Genome Expression in Lymphoma, Leukemia and Multiple MyelomaCompletedNCT00339963
- Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1CompletedNCT00339638
- Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell LymphomaCompletedNCT00338494Phase 1
- Gemcitabine for Marginal Zone LymphomaTerminatedNCT00337259Phase 2
- Zevalin Plus BuCyE High-dose Therapy in B-cell Non-Hodgkin's LymphomaCompletedNCT00336843Phase 2
- Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's LymphomaCompletedNCT00334438Phase 1
- A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.Status unknownNCT00333008Phase 2
- Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment OutcomeCompletedNCT00327132Not applicable
- GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell LymphomaSuspendedNCT00324831Phase 3
- Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic LeukemiaCompletedNCT00324779Phase 2